US20230203538A1 - In vivo targeting of Fibrosis by anti-CD5

Progress in drug delivery system for fibrosis therapy - ScienceDirect

In vivo production of CAR-T cells using CD5/LNP-FAPCAR

Mouse Monoclonal Anti-CD45 Antibody (MEM-28). Tested Applications: Western Blot, Flow Cytometry, ICC, IHC, IHC-Paraffin, IP. Tested Reactivity: Human.

CD45 Antibody (MEM-28) - BSA Free (NB500-319): Novus Biologicals

Frontiers Novel Anti-fibrotic Therapies

CD352 (NTB-A) Antibody, anti-human, REAfinity™

Antibody-drug conjugates targeting CD248 inhibits liver fibrosis

Discovery of a new class of integrin antibodies for fibrosis

In vivo production of CAR-T cells using CD5/LNP-FAPCAR

CD63 Antibody (MX-49.129.5) SCBT - Santa Cruz Biotechnology